Temporal trends and spatial patterns of Hepatitis C-related mortality in Brazil
DOI:
https://doi.org/10.11606/s1518-8787.2025059006139Palavras-chave:
Hepatitis C, Mortality, Spatial Analysis, Time Series Study, EpidemiologyResumo
OBJECTIVE: To analyze the trends and spatial patterns of hepatitis C-related mortality in Brazil
from 2000 to 2020. METHODS: A population-based, mixed ecological study of spatial and temporal trends, using secondary data from death certificate (DC) registries, in which hepatitis C was mentioned as an underlying or associated cause of mortality. Temporal trends were analyzed by joinpoint regression, and spatial analysis by the distribution of adjusted rates by age and sex, and spatial autocorrelation by the local Moran index and the Getis-Ord Gi* index (Gi star). RESULTS: From 2000 to 2020, 64,029 deaths due to hepatitis C were recorded in the Mortality Information System (SIM), representing 0.26% of deaths in Brazil. Most deaths were due to underlying causes (n = 33,652, 52.6%). Areas with high rates in all five analyzed periods were identified in the states of São Paulo, southern Minas Gerais, southern Rio de Janeiro, northern Paraná, southern and coastal Santa Catarina, eastern Mato Grosso do Sul, and Rio Grande do Sul. The states of Acre and southern Amazonas showed high rates after 2004, which spread to northern Rondônia from 2016 to 2020. The joinpoint regression model showed an increasing trend in hepatitis C mortality in Brazil from 2000 to 2015, but a decreasing trend from 2016-2020. The mortality rate was higher in men and people over sixty years of age. CONCLUSION: Differences were observed in the temporal and spatial trend of hepatitis C mortality in different regions of Brazil. These data may support the design of hepatitis C elimination strategies in Brazil, according to regional specificities.
Referências
Barré T, Bourlière M, Parlati L, Ramier C, Marcellin F, Protopopescu C et al. Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort). Drug Alcohol Review. 2024;43(3): 718–31. https://doi.org/10.1111/dar.13802
Pereira LMMB, Martelli CMT, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso RMA et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: A crosssectional study. BMC Infect Dis. 2013;13(1). https://doi.org/10.1186/1471-2334-1360
Ministério da Saúde (BR). Boletim Epidemiológico - Hepatites Virais 2023 Departamento de HIV/Aids, Tuberculose, Hepatites Virais e Infecções Sexualmente Transmissíveis. Secretaria de Vigilância em Saúde e Ambiente [Internet]. Brasília, DF: Ministério da Saúde; 2023. [cited 2024 Jan 2024] Available from: https://www.gov.br/aids/pt-br/central-de-conteudo/boletinsepidemiologicos/ 2023/hepatites-virais/boletim-epidemiologico-hepatites-virais-_-2023.pdf/view
Pawlotsky JM, Negro F, Aghemo A, Berenguer M, Dalgard O, Dusheiko G et al. EASL recommendations on treatment of hepatitis C: Final update of the series. J Hepatol. 2020 Nov;73(5):1170–218. https://doi.org/10.1016/j.jhep.2020.08.018
Lobato CMO, Codes L, Silva GF, Souza AFM, Coelho HSM, Pedroso MLA et al. Direct antiviral herapy for treatment of hepatitis C: A real-world study from Brazil. Annals of Hepatology, 2019 Nov-Dec;18(6):849–54. https://doi.org/10.1016/j.aohep.2019.08.001
Perazzo H, Pacheco AG, Luz PM, Castro R, Hyde C, Fittipaldi J et al. Age-standardized mortality rates related to viral hepatitis in Brazil. BMC Infectious Diseases. 2017 July;17(1):527. https://doi.org/10.1186/s12879-017-2619-y
Brito RJVC, Silva LF, Santos MB, Moura PMMF, Souza CDF, Carmo RF. A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018. BMC Infec Dis. 2022 Jan;22(1):81. https://doi.org/10.1186/s12879-022-07063-5
Sousa LFO, Santos ERS, Oliveira RM, Andrade RLB, Batista JFC, Lima SO. Hepatitis mortality in Brazil and regions, 2001–2020: temporal trend and spatial analysis. Rev bras epidemiol. 2023;26:e230029. https://doi.org/10.1590/1980-549720230029
Instituto Brasileiro de Geografia e Estatística (IBGE). Cidades e Estados [Internet]. Rio de Janeiro; 2023 [cited 2023 Jul 18]. Available from: https://www.ibge.gov.br/cidades-e-estados/
Instituto de Pesquisa Econômica Aplicada (IPEA). Atlas da Vulnerabilidade Social nos Municípios Brasileiros [Internet]. Brasília, DF: IPEA; 2015 [cited 2023 Feb 4]. Available from: http://ivs.ipea.gov.br
Instituto Brasileiro de Geografia e Estatística (IBGE). Características gerais dos domicílios e dos moradores 2019 – PNAD Contínua. Pesquisa Nacional por Amostra de Domicílios Contínua. Rio de Janeiro: IBGE; 2020.
Organização Mundial da Saúde (OMS). International Statistical Classification of Diseases and Related Health Problems 10th Revision. ICD-10 Version: 2019 [Internet]. Geneva; 2019 [cited 2024 Feb 4]. Available from: https://icd.who.int/browse10/2019/en
Ministério da Saúde (BR). Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Plano para Eliminação da Hepatite C no Brasil. Brasília, DF: Ministério da Saúde, 2018. [cited 2024 Apr 04]. Available from: http://www.aids.gov.br/pt-br/pub/2019/
Ministério da Saúde (BR). População Residente - Estudo de Estimativas Populacionais por Município, Idade e Sexo 2000-2020. Informações de Saúde (TABNET). DATASUS [Internet]. Brasília, DF: Ministério da Saúde; 2021 [cited 2024 Feb 4]. Available from: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?ibge/cnv/popsvsbr.def
StataCorp LLC. Stata 11©. College Station [Internet]. Lakeway; 2021 [cited 2023 Feb 4]. Available from: https://www.stata.com/stata11/
National Cancer Institute (USA). Joinpoint Trend Analysis Software [Internet]. Calverton; 2021 [cited 2023 Mar 2]. Available from: https://surveillance.cancer.gov/joinpoint
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics Med. 2000 Jan;19(3):335–51. https://doi.org/10.1002/ (SICI)1097-0258(20000215)19:3%3C335::AID-SIM336%3E3.0.CO;2-Z
Dunn CE, Kingham SP, Rowlingson B, Bhopal RS, Cockings S, Foy CJW, et al. Analysing spatially referenced public health data: A comparison of three methodological approaches. Health Place. 2001 Mar;7(1):1–12. https://doi.org/10.1016/s1353-8292(00)00033-2
Anselin L. Local Indicators of Spatial Association–LISA. Geogr Anal. 1995 Apr; 27(2):93–115. https://doi.org/10.1111/j.1538-4632.1995.tb00338.x
World Health Organization (WHO). Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis [Internet]. Geneva; 2016. [cited 2024 Apr 04]. Available from: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO?sequence=1
Brasil. Plano para Eliminação da Hepatite C no Brasil. Brasília, DF: Ministério da Saúde; 2018 [cited 2024 Apr 04]. Available from: https://www.gov.br/aids/pt-br/central-de-conteudo/publicacoes/2019/plano-para-eliminacao-da-hepatite-c-no-brasil
Hamill V, Wong S, Benselin J, Krajden M, Hayes PC, Mutimer D et al. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study. BMJ. 2023 Aug;382:e074001. https://doi.org/10.1136/bmj-2022-074001
Dantas TOM. Aspectos epidemiológicos da infecção pelo vírus da hepatite C e coinfecções com os vírus B e delta no estado do Acre, Amazônia Ocidental Brasileira [Internet]. Brasília, DF. Tese [Doutorado]. – Universidade de Brasília, Núcleo de Medicina Tropical; 2010 [cited 2024 Apr 04]. Available from: http://repositorio2.unb.br/jspui/handle/10482/8157
Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019 Feb; 4(2):135–84. https://doi.org/10.1016/S2468-1253(18)30270-X
World Health Organization (WHO). Global health sector strategy on viral hepatitis 2016-2021. Global Hepatitis Programme Department of HIV/AIDS. Geneva; 2016. Available from: https://iris.who.int/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1
Diógenes VHD, Pinto Júnior EP, Gonzaga MR, Queiroz BL, Lima EEC, Costa LCC, et al. Differentials in death count records by databases in Brazil in 2010. Rev Saúde Pública. 2022;56:1-11. https://doi.org/10.11606/s1518-8787.2022056004282
Erman A, Sahakyan Y, Everett K, Greenaway C, Janjua N, Kwong JC et al. Hepatitis C Attributable Healthcare Costs and Mortality among Immigrants: A Population-Based Matched Cohort Study. Can J Gastroenterol Hepatol. 2024;1. https://doi.org/10.1155/2024/5573068
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2025 Elodie Bomfim Hyppolito, Alberto Novaes Ramos Júnior, Anderson Fuentes Ferreira, Thor Oliveira Dantas, José Milton de Castro Lima, Taynara Laís Silva, Roberto da Justa Pires Neto
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
